Amphastar Pharmaceuticals AMPH Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's capital investments accrued but not yet paid?
- Amphastar Pharmaceuticals (AMPH) reported capital investments accrued but not yet paid of $4.17M in Q1 2026.
- How has Amphastar Pharmaceuticals's capital investments accrued but not yet paid changed year-over-year?
- Amphastar Pharmaceuticals's capital investments accrued but not yet paid decreased by 42.2% year-over-year, from $7.22M to $4.17M.